Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

著者: Zoe Boyer‐Díaz, Peio Aristu-Zabalza, María Andrés‐Rozas, Claude Robert, Martí Ortega‐Ribera, Anabel Fernández‐Iglesias, Pierre Broqua, Jean-Louis Junien, Guillaume Wettstein, Jaime Bosch, Jordi Gracia‐Sancho - Journal of Hepatology 2020 被引用: 163